News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,064 Results
Type
Article (68687)
Company Profile (467)
Press Release (694894)
Multimedia
Podcasts (175)
Webinars (25)
Section
Business (199811)
Career Advice (3824)
Deals (35885)
Drug Delivery (146)
Drug Development (85809)
Employer Resources (204)
FDA (17320)
Job Trends (15847)
News (349365)
Policy (35373)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2978)
Academic (1)
Accelerated approval (33)
Adcomms (36)
Allergies (148)
Alliances (50735)
ALS (180)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (343)
Approvals (17504)
Artificial intelligence (574)
Autoimmune disease (158)
Automation (34)
Bankruptcy (359)
Best Places to Work (12347)
BIOSECURE Act (23)
Biosimilars (201)
Biotechnology (322)
Bladder cancer (161)
Brain cancer (64)
Breast cancer (660)
Cancer (4997)
Cardiovascular disease (441)
Career advice (3278)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (36)
Clinical research (72627)
Collaboration (1809)
Company closure (5)
Compensation (1103)
Complete response letters (73)
COVID-19 (2972)
CRISPR (99)
C-suite (859)
Cystic fibrosis (154)
Data (6254)
Decentralized trials (2)
Denatured (61)
Depression (150)
Diabetes (527)
Diagnostics (7025)
Digital health (43)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (273)
Drug pricing (223)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (81135)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (123210)
Executive appointments (1015)
FDA (20476)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1535)
Gene editing (214)
Generative AI (51)
Gene therapy (666)
GLP-1 (1117)
Government (5321)
Grass and pollen (8)
Guidances (384)
Healthcare (20578)
HIV (58)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (289)
Immuno-oncology (59)
Indications (99)
Infectious disease (3256)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (247)
Interviews (746)
IPO (16969)
IRA (60)
Job creations (3882)
Job search strategy (2647)
JPM (68)
Kidney cancer (16)
Labor market (93)
Layoffs (633)
Leadership (40)
Legal (8406)
Liver cancer (98)
Longevity (16)
Lung cancer (677)
Lymphoma (378)
Machine learning (44)
Management (66)
Manufacturing (832)
MASH (172)
Medical device (14480)
Medtech (14532)
Mergers & acquisitions (19998)
Metabolic disorders (1384)
Multiple sclerosis (162)
NASH (23)
Neurodegenerative disease (354)
Neuropsychiatric disorders (97)
Neuroscience (3101)
Neurotech (1)
NextGen: Class of 2026 (7431)
Non-profit (5043)
Now hiring (54)
Obesity (673)
Opinion (336)
Ovarian cancer (166)
Pain (211)
Pancreatic cancer (229)
Parkinson's disease (299)
Partnered (35)
Patents (507)
Patient recruitment (480)
Peanut (60)
People (60362)
Pharmaceutical (87)
Pharmacy benefit managers (32)
Phase 1 (22662)
Phase 2 (31777)
Phase 3 (23959)
Pipeline (5060)
Policy (334)
Postmarket research (2811)
Preclinical (9750)
Press Release (71)
Prostate cancer (246)
Psychedelics (55)
Radiopharmaceuticals (300)
Rare diseases (904)
Real estate (6237)
Recruiting (80)
Regulatory (26278)
Reports (67)
Research institute (2685)
Resumes & cover letters (593)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (255)
Series B (197)
Service/supplier (12)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (172)
Sponsored (48)
Startups (3791)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (99)
The Weekly (112)
Vaccines (1133)
Venture capital (96)
Weight loss (459)
Women's health (86)
Worklife (21)
Date
Today (130)
Last 7 days (544)
Last 30 days (2464)
Last 365 days (31682)
2026 (2499)
2025 (32011)
2024 (37074)
2023 (41834)
2022 (53134)
2021 (57918)
2020 (56713)
2019 (50352)
2018 (38268)
2017 (35340)
2016 (35246)
2015 (40533)
2014 (33129)
2013 (30702)
2012 (30189)
2011 (30562)
2010 (28363)
Location
Africa (1104)
Alabama (87)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (45513)
Australia (7966)
California (11272)
Canada (3274)
China (1159)
Colorado (470)
Connecticut (494)
Delaware (333)
Europe (104834)
Florida (1670)
Georgia (363)
Hawaii (3)
Idaho (65)
Illinois (914)
India (64)
Indiana (508)
Iowa (24)
Japan (425)
Kansas (129)
Kentucky (41)
Louisiana (27)
Maine (83)
Maryland (1415)
Massachusetts (8304)
Michigan (350)
Minnesota (636)
Mississippi (6)
Missouri (130)
Montana (35)
Nebraska (28)
Nevada (124)
New Hampshire (85)
New Jersey (3051)
New Mexico (33)
New York (2990)
North Carolina (1549)
North Dakota (9)
Northern California (5416)
Ohio (348)
Oklahoma (22)
Oregon (46)
Pennsylvania (2268)
Puerto Rico (22)
Rhode Island (48)
South America (1437)
South Carolina (63)
South Dakota (1)
Southern California (4399)
Tennessee (169)
Texas (1770)
United States (40572)
Utah (339)
Vermont (1)
Virginia (275)
Washington D.C. (84)
Washington State (953)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
764,064 Results for "be the match biotherapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Animate Biosciences’ Engineered Peptides Match or Exceed Standard Therapy in Preclinical Lung Fibrosis Models
January 14, 2026
·
3 min read
Rare diseases
As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation?
This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question whether they will be enough to net their developers a significant share of the entrenched market.
December 1, 2025
·
5 min read
·
Ben Hargreaves
BioMidwest
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport, a leading global provider of innovative products and services to the fast-growing cell & gene therapy industry enabling the future of medicine for a new era of life sciences, announced a new strategic partnership.
October 9, 2023
·
4 min read
Press Releases
Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group
October 17, 2025
·
3 min read
BioMidwest
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
In anticipation of Cord Blood Awareness Month this July, Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, announced the formation of the Be The Match BioTherapies Cord Blood Bank Alliance.
July 10, 2023
·
3 min read
Obesity
Novo’s Metsera Bid Attracts FTC Scrutiny as Pfizer Matches $10B Offer
Pressure from the FTC and Pfizer is building around Novo Nordisk’s bid to snatch obesity biotech Metsera. The antitrust watchdog has spotted issues with the structure of Novo’s bid, while its New York-based rival has put more money on the table.
November 6, 2025
·
3 min read
·
Tristan Manalac
Press Releases
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
October 15, 2025
·
6 min read
BioMidwest
NMDP BioTherapies Introduces Enhanced Cellular Materials for Allogeneic Cell Therapy Development
NMDP BioTherapies ℠, formerly Be The Match BioTherapies unveiled substantial upgrades to its cellular starting material offerings, including incorporating a Drug Master File (DMF) with its rapid-delivery, standard GMP leukopak to simplify regulatory filings.
April 16, 2024
·
4 min read
Press Releases
AABB To Run Limited-Time Certified Advanced Biotherapies Professional (CABP) Free Exam Retake Offer
December 1, 2025
·
1 min read
Press Releases
Centinel Spine® Receives Two-Level FDA Approval for prodisc® C Vivo and prodisc® C SK Match-the-Disc™ Cervical Total Disc Replacement Devices
October 15, 2025
·
5 min read
1 of 76,407
Next